Can-Fite BioPharma Files 6-K, Incorporates Press Release

Ticker: CANF · Form: 6-K · Filed: Feb 18, 2025 · CIK: 1536196

Can-Fite Biopharma LTD. 6-K Filing Summary
FieldDetail
CompanyCan-Fite Biopharma LTD. (CANF)
Form Type6-K
Filed DateFeb 18, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: filing, registration-statement, foreign-private-issuer

Related Tickers: CANF

TL;DR

Can-Fite BioPharma filed a 6-K on Feb 18, 2025, linking to prior filings. Nothing new, just housekeeping.

AI Summary

On February 18, 2025, Can-Fite BioPharma Ltd. filed a Form 6-K, incorporating by reference a press release. This filing is related to its existing Registration Statements on Form S-8 and Form F-3, which are used for registering securities offerings. The company is a foreign private issuer based in Israel.

Why It Matters

This filing updates the company's disclosures and is incorporated into existing registration statements, potentially impacting investors' understanding of its ongoing securities activities.

Risk Assessment

Risk Level: low — The filing is a routine report of a foreign private issuer and does not appear to contain new material financial or operational information.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K is to report information required by foreign private issuers and to incorporate by reference a press release into the registrant's existing Registration Statements on Form S-8 and Form F-3.

When was this Form 6-K filed?

This Form 6-K was filed on February 18, 2025.

What are the file numbers for the incorporated Registration Statements?

The incorporated Registration Statements include Form S-8 (File Nos. 333-227753, 333-271384, and 333-278525) and Form F-3 (File Nos. 333-236064, 333-274316, 333-262055, 333-276000, and 333-281872).

Where is Can-Fite BioPharma Ltd. located?

Can-Fite BioPharma Ltd. is located at 26 Ben Gurion Street, Ramat Gan, 5257346, Israel.

Does Can-Fite BioPharma Ltd. file annual reports under Form 20-F or Form 40-F?

Can-Fite BioPharma Ltd. indicates that it files annual reports under Form 20-F.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on February 18, 2025 regarding Can-Fite BioPharma Ltd. (CANF).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing